Lauren A. Daniel
5am Venture Management, Llc
Assets Managed
$360.209M
Holdings
20
Last Quarter
2026 - Q1
Filed Date
11d ago
Growth Rate
13.24%(2Q avg: 14.87%)
Sustained Growth
3 quarters
Portfolio positions
This chart displays the top 10 holdings in 5am Venture Management, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 20 positions.
Assets under management
The assets under management (AUM) of 5am Venture Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 360.209M in assets, with a quarterly growth rate of 13.24% and a 2-quarter average growth rate of 14.87%. The portfolio is managed by Lauren A. Daniel, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
ERAS Erasca Inc
| 15.66% | $56.403M 3.486M shares@ $16.19 avg price | Decreased -35.5% |
TRDA Entrada Therapeutics Inc
| 14.22% | $51.192M 4.056M shares@ $12.63 avg price | |
TYRA Tyra Biosciences Inc
| 10.95% | $39.422M 1.029M shares@ $38.3 avg price | |
CAMP Camp4 Therapeutics Corp
| 7.19% | $25.883M 5.869M shares@ $4.41 avg price | |
CNTA Centessa Pharmaceuticals-adr
| 6.41% | $23.075M 580,945 shares@ $39.72 avg price | |
PHVS Pharvaris Nv
| 6.26% | $22.532M 797,600 shares@ $28.25 avg price | |
MPLT Maplight Therapeutics Inc
| 5.37% | $19.314M 950,011 shares@ $20.34 avg price | |
TECX Tectonic Therapeutic Inc
| 5.21% | $18.752M 606,660 shares@ $30.92 avg price | |
CLDX Celldex Therapeutics Inc
| 4.38% | $15.773M 497,270 shares@ $31.72 avg price | |
ARTV Artiva Biotherapeutics Inc
| 4.21% | $15.155M 2.353M shares@ $6.45 avg price |
1-10 of 20